OQZ
2010-07-01
Anti-Mutated Citrullinated Vimentin Igg
FDA product code OQZ · 1 cleared devices
Class 2
Immunology
- Regulation
- 21 CFR 866.5775
- Review panel
- IM
- Implant
- No
- Life sustaining
- No
- Third party review
- Yes
- GMP exempt
- No
- Clearance span
- 2010-07-01 – 2010-07-01
For the semi-quantitative measurement of IgG class autoantibodies against mutated citrullinated vimentin (MCV) in human serum or plasma.
No matching devices.
Advertisement